11490 Federal Register / Vol. 76, No. 41 / Wednesday, March 2, 2011 / Notices 

AboutAdvisoryCommittees/ 

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: February 24, 2011. 

Thinh Nguyen, 

Acting Associate Commissioner for Special 

Medical Programs. 

[FR Doc. 2011–4614 Filed 3–1–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0033] 

Withdrawal of Approval of New Animal 

Drug Applications; Phenylbutazone; 

Pyrantel; Tylosin; Sulfamethazine 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is withdrawing 

approval of eight new animal drug 

applications (NADAs). In a final rule 

published elsewhere in this issue of the 

Federal Register, FDA is amending the 

regulations to remove portions reflecting 

approval of these NADAs. 

DATES: Withdrawal of approval is 

effective March 14, 2011. 

FOR FURTHER INFORMATION CONTACT: John 

Bartkowiak, Center for Veterinary 

Medicine (HFV–212), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–276–9079, email: john.bartkowiak@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

sponsors in table 1 have requested that 

FDA withdraw approval of the three 

NADAs listed because the products are 

no longer manufactured or marketed. 

TABLE 1—VOLUNTARY REQUESTS FOR WITHDRAWAL OF APPROVAL (WOA) OF THREE NADAS

Sponsor 

NADA No. 

product 

(established name of drug) 

21 CFR Section 

affected 

(sponsor drug 

labeler code) 

First Priority, Inc., 1590 Todd Farm Dr., Elgin, IL 60123 .......... NADA 48–647, Phenylbutazone boluses (phenylbutazone) .... 520.1720a 

(058829). 

Yoder Feed, Division of Yoder, Inc., Kalona, IA 52247 ............ NADA 96–161, Hy-Con TYLAN Premix (tylosin phosphate) ... 558.625

(035369). 

Triple ‘‘F’’, Inc., 10104 Douglas Ave., Des Moines, IA 50322 ... NADA 119–062, Cadco-BN–10 BANMINTH Premix (pyrantel 

tartrate).

558.485 

(011490). 

Truow Nutrition, Inc., 1590 Todd 

Farm Dr., Elgin, IL 60123 (Truow), has 

informed FDA that it is the sponsor of 

five feed premix NADAs previously 

owned by milling companies, which it 

purchased. NADA 100–352 was owned 

by NutriBasics Co., last doing business 

at P.O. Box 1014, Willmar, MN 56201. 

NADA 107–002 and NADA 123–000 

were owned by Seeco, Inc., also last 

doing business at P.O. Box 1014, 

Willmar, MN 56201. NADA 133–833 

and NADA 135–243 were owned by 

Southern Micro-Blenders, Inc., last 

doing business at 3801 North 

Hawthorne St., Chattanooga, TN 37406. 

Truow has requested that FDA 

withdraw approval of the five NADAs in 

table 2 because they are no longer 

manufactured or marketed. 

TABLE 2—VOLUNTARY REQUESTS FOR WOA OF FIVE NADAS BY TRUOW NUTRITION, INC. 

Previous sponsor NADA No., product 

(established name of drug) 

21 CFR section 

affected 

(sponsor drug 

labeler code) 

NutriBasics Co., North Highway 71, P.O. Box 1014, 

Willmar, MN 56201.

NADA 100–352, Seeco T–10 Premix (tylosin phosphate) .... 558.625 (053740). 

Seeco, Inc., P.O. Box 1014, North Highway 71, Willmar, 

MN 56201.

NADA 107–002, Seeco TYLAN–Sulfa 10 Premix (tylosin 

phosphate and sulfamethazine).

Not codified. 

Seeco, Inc., P.O. Box 1014, North Highway 71, Willmar, 

MN 56201.

NADA 123–000, Super Swine Wormer B–9 BANMINTH 

(pyrantel tartrate).

558.485 (011749). 

Southern Micro-Blenders, Inc., 3801 North Hawthorne St., 

Chattanooga, TN 37406.

NADA 133–833, TYLAN 10 Premix (tylosin phosphate) ...... 558.625 (049685). 

Southern Micro-Blenders, Inc., 3801 North Hawthorne St., 

Chattanooga, TN 37406.

NADA 135–243, Swine Guard-BN BANMINTH Premix 

(pyrantel tartrate).

558.485 (049685). 

Therefore, under authority delegated 

to the Commissioner of Food and Drugs 

and redelegated to the Center for 

Veterinary Medicine, and in accordance 

with § 514.116 Notice of withdrawal of 

approval of application (21 CFR 

514.116), notice is given that approval 

of NADAs 48–647, 96–161, 100–352, 

107–002, 119–062, 123–000, 133–833, 

and 135–243, and all supplements and 

amendments thereto, is hereby 

withdrawn, effective March 14, 2011. 

In a final rule published elsewhere in 

this issue of the Federal Register, FDA 

is amending the animal drug regulations 

to reflect the withdrawal of approval of 

these NADAs. 

Dated: February 18, 2011. 

Bernadette Dunham, 

Director, Center for Veterinary Medicine. 

[FR Doc. 2011–4545 Filed 3–1–11; 8:45 am] 

BILLING CODE 4160–01–P 


emcdonald on DSK2BSOYB1PROD with NOTICES